Cargando…
Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755103/ https://www.ncbi.nlm.nih.gov/pubmed/36112306 http://dx.doi.org/10.1007/s43441-022-00461-6 |
| _version_ | 1784851353450840064 |
|---|---|
| author | Schulthess, Duane Bowen, Harry P. Popovian, Robert Gassull, Daniel Zhang, Augustine Hammang, Joe |
| author_facet | Schulthess, Duane Bowen, Harry P. Popovian, Robert Gassull, Daniel Zhang, Augustine Hammang, Joe |
| author_sort | Schulthess, Duane |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9755103 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97551032022-12-17 Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals Schulthess, Duane Bowen, Harry P. Popovian, Robert Gassull, Daniel Zhang, Augustine Hammang, Joe Ther Innov Regul Sci Correction Springer International Publishing 2022-09-16 2023 /pmc/articles/PMC9755103/ /pubmed/36112306 http://dx.doi.org/10.1007/s43441-022-00461-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Schulthess, Duane Bowen, Harry P. Popovian, Robert Gassull, Daniel Zhang, Augustine Hammang, Joe Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals |
| title | Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals |
| title_full | Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals |
| title_fullStr | Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals |
| title_full_unstemmed | Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals |
| title_short | Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals |
| title_sort | correction: the relative contributions of nih and private sector funding to the approval of new biopharmaceuticals |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755103/ https://www.ncbi.nlm.nih.gov/pubmed/36112306 http://dx.doi.org/10.1007/s43441-022-00461-6 |
| work_keys_str_mv | AT schulthessduane correctiontherelativecontributionsofnihandprivatesectorfundingtotheapprovalofnewbiopharmaceuticals AT bowenharryp correctiontherelativecontributionsofnihandprivatesectorfundingtotheapprovalofnewbiopharmaceuticals AT popovianrobert correctiontherelativecontributionsofnihandprivatesectorfundingtotheapprovalofnewbiopharmaceuticals AT gassulldaniel correctiontherelativecontributionsofnihandprivatesectorfundingtotheapprovalofnewbiopharmaceuticals AT zhangaugustine correctiontherelativecontributionsofnihandprivatesectorfundingtotheapprovalofnewbiopharmaceuticals AT hammangjoe correctiontherelativecontributionsofnihandprivatesectorfundingtotheapprovalofnewbiopharmaceuticals |